Helen of Troy in the news

Zacks Research cut Helen of Troy's FY2026 earnings estimates sharply and rated the stock a strong sell amid mixed analyst opinions and recent earnings miss.

Helen of Troy's stock faces mixed analyst ratings amid slightly missed earnings and declining revenue, with institutional investors increasing positions.

Helen of Troy's stock price target update highlights shifting analyst views on its fair value, encouraging investors to track evolving valuations and narratives.

Helen of Troy's stock price target update highlights shifting analyst views on its fair value, encouraging investors to track evolving valuations and community insights.

Helen of Troy's stock has fallen nearly 30% over the past year amid consumer demand and margin pressures, with Wall Street cautiously optimistic about moderate recovery potential.

Helen of Troy saw a significant decline in short interest in December, reported slightly missed Q4 earnings, and has mixed analyst ratings with a $22 average price target.

Helen of Troy’s Q3 2026 sales declined due to tariffs and softer demand, prompting a strategic shift to invest in brand innovation and growth while managing tariff impacts and aiming for fiscal 2027 as a turnaround year.

Helen of Troy's Q3 2026 sales declined due to tariff impacts and market softness, with margins pressured but tariff mitigation and new product launches underway.

Helen of Troy's Q3 2026 sales declined due to tariffs and China market challenges, prompting a strategic shift to invest in brand innovation and growth, with fiscal 2027 targeted as a turnaround year.

Helen of Troy's Q3 results beat expectations but a lowered outlook and portfolio challenges led UBS and Canaccord to reduce price targets and maintain cautious ratings.

Helen of Troy's earnings are understated due to impairment charges, but strong margins and strategic changes suggest significant undervaluation and upside.

UBS and Canaccord downgraded Helen of Troy's price targets and maintained cautious ratings due to mixed Q3 results and ongoing portfolio challenges.

Helen of Troy faces balanced risk and reward due to early portfolio changes, tariff costs, and high leverage, resulting in a Hold rating.

Helen of Troy reported mixed Q3 results with revenue beating estimates but lowered its fiscal 2026 earnings forecast, causing shares to fall and analysts to cut price targets.

Canaccord Genuity keeps a 'Hold' rating on Helen Of Troy, lowering its price target to $22 amid cautious market outlooks.

Helen of Troy reported Q3 earnings in line with estimates but lowered its fiscal 2026 EPS and sales forecasts, causing shares to fall and analysts to cut price targets.

Helen of Troy's stock target was lowered due to tariff and profitability pressures despite strong Q3 sales and CEO plans to invest in growth.

Helen of Troy's Q3 2026 earnings met expectations amid tariff challenges; the company is investing in brand innovation and growth to stabilize and improve performance, focusing on revenue growth over cost-cutting.

Helen of Troy reported Q3 sales decline due to tariffs and consumer pressures, shifting to a growth-focused strategy emphasizing brand revitalization and tariff mitigation.

Helen of Troy beat Q3 earnings and revenue estimates but provided FY 2026 EPS guidance below analyst expectations.